HB272, the Protecting Life and Taxpayers Act of 2025, would bar any federal funds to an entity unless it certifies it will not perform abortions and will not provide funds to any other entity that performs abortions during the funding period. The act applies to direct funding and funded contracts, extending the prohibition to pass-through arrangements where funds reach abortion activities indirectly.
The bill creates a broad definition of "entity" that covers the entire legal entity and any controlled affiliates. It also provides two narrow exceptions: abortions in cases of rape or incest, and abortions performed to save the woman's life when a physician certifies a life-threatening condition.
The policy would impact any recipient of federal funding, including health care providers, universities, and other grant or contract recipients, and would necessitate new compliance reviews and certifications to maintain eligibility.
At a Glance
What It Does
No Federal funds may be provided to an entity unless the entity certifies it will not perform abortions and will not fund any other entity that performs abortions. The prohibition extends to indirect funding through contracts or subcontracts.
Who It Affects
Recipients of federal funds, including hospitals, clinics, universities, grantees, and contractors, along with entities in funded programs that could be linked to abortion services.
Why It Matters
The bill imposes a broad, enforceable condition on federal funding, potentially reshaping how funds flow through health, research, and public programs and creating tight compliance expectations for partner organizations.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The Protecting Life and Taxpayers Act of 2025 would impose a certification-based condition on every recipient of federal funds. An entity must certify that during the funding period it will not perform abortions and will not provide funds to any other entity that performs abortions.
This applies directly to grants and contracts and also to indirect funding passed through subcontractors or affiliated entities. The statute defines “entity” to include the entire legal entity and any organization under common control, meaning a parent company cannot easily shield a subsidiary that performs abortions from the funding restriction.
Two exceptions exist: abortions in cases of rape or incest, and abortions necessary to save the life of the pregnant woman where a physician certifies a life-threatening condition caused by the pregnancy. These exceptions are narrowly tailored and require physician certification or documentation for rape/incest scenarios.
The bill would apply to any recipient of federal funds, spanning hospitals, health systems, universities, research institutions, and other grant or contract recipients, creating a comprehensive compliance framework for funding streams.
The Five Things You Need to Know
The bill requires certification from any recipient of federal funds that it will not perform abortions during the funding period.
Direct funding and indirect funding via contracts are both covered by the prohibition.
The definition of entity includes the entire legal entity and any affiliates under common control.
Two narrow exceptions exist: abortions due to rape or incest, and life-saving abortions with physician certification.
Compliance and enforcement would require additional documentation and oversight for all federally funded programs.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Section 1 designates the act as the Protecting Life and Taxpayers Act of 2025, establishing the official nomenclature for the statute.
Prohibition on abortion funding
Section 2 imposes the core funding restriction. No federal funds may be provided to an entity unless the entity certifies that it will not perform abortions and will not provide any funds to other entities that perform abortions during the period of the funding. Subsection (a) sets the prohibition; subsection (b) provides two limited exceptions for rape or incest and for life-threatening conditions; subsection (c) defines “entity” to include the entire legal entity and entities under common control.
Definitions and scope
Section 2(c) defines the term “entity” to encompass the whole legal entity and any controlled or controlling affiliates. This broad scope ensures that funding restrictions capture organizational structures that could otherwise route funds to abortion services through related entities. The practical effect is a high bar for recipients to demonstrate channeling funds away from abortion-related activities.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Hospitals and health systems that do not perform abortions and rely on federal funds to operate benefit from clearer eligibility criteria and reduced risk of indirect funding to abortion activities.
- Federally funded health clinics and community health centers that avoid abortion services gain clearer compliance expectations and reduced risk of funding being misallocated to abortion providers.
- Research universities and medical centers receiving federal grants but not involved in abortion services benefit from a uniform funding standard that prevents funds from supporting abortion-related activities in affiliated units.
- Federal program administrators and funding agencies gain a straightforward mechanism to enforce moral or policy-based funding restrictions across complex organizational structures.
Who Bears the Cost
- Organizations that perform abortions or that indirectly fund abortion providers lose access to federal funds, potentially disrupting services or research programs.
- Entities with complex, multi-affiliate structures may incur higher compliance costs to ensure all affiliates are certifying appropriately.
- Contractors and subcontractors in federally funded projects may face additional documentation and verification burdens to prove they meet the certification requirements.
- State and local governments administering federally funded programs may need new governance processes to monitor compliance across grants and contracts.
- Taxpayers could experience shifts in funding availability for certain programs if funds are withheld due to failure to certify or enforce the prohibition.
Key Issues
The Core Tension
The central dilemma is whether a sweeping prohibition on funding for abortion-related activities can be implemented without chilling legitimate medical care in rape/incest or life-threatening cases, while also preventing federal funds from being used to support abortions. The broad “entity” concept and pass-through funding raise questions about enforcement, accountability, and potential unintended consequences for patients and research alike.
The bill raises several policymaking and implementation questions. The breadth of the term “entity” — covering the entire legal entity and entities under common control — increases the risk that a single abortion-related activity within a parent company could jeopardize federal funding across multiple subsidiaries or programs.
The prohibition also extends to indirect funding through contracts and subcontracts, which creates potential pathways for circumvention unless robust verification and audit mechanisms are in place. The two exceptions—rape or incest and life-threatening medical conditions—are narrowly framed and rely on physician certification or explicit qualifying circumstances, leaving room for disputes about medical necessity or the chain of custody for certification.
The bill lacks explicit enforcement provisions, penalties, or timelines for achieving compliance, which could affect how readily agencies implement and monitor the rule. These gaps invite questions about how to verify compliance, how to treat entities with shared services but separate legal status, and what recourse exists for entities that believe the prohibition is overbroad or incorrectly applied.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.